Olema Pharmaceuticals inc (OLMA)
12.19
-0.03
(-0.25%)
USD |
NASDAQ |
Sep 27, 16:00
12.19
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals Cash from Operations (Quarterly): -27.56M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -27.56M |
| March 31, 2024 | -23.50M |
| December 31, 2023 | -18.48M |
| September 30, 2023 | -22.74M |
| June 30, 2023 | -22.12M |
| March 31, 2023 | -20.39M |
| December 31, 2022 | -19.71M |
| September 30, 2022 | -17.99M |
| June 30, 2022 | -26.46M |
| Date | Value |
|---|---|
| March 31, 2022 | -17.90M |
| December 31, 2021 | -18.60M |
| September 30, 2021 | -12.10M |
| June 30, 2021 | -8.905M |
| March 31, 2021 | -11.08M |
| December 31, 2020 | -9.013M |
| September 30, 2020 | -7.536M |
| June 30, 2020 | -1.181M |
| March 31, 2020 | -2.136M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-27.56M
Minimum
Jun 2024
-1.181M
Maximum
Jun 2020
-15.97M
Average
-18.23M
Median
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.854M |
| Theriva Biologics Inc | -3.452M |
| Oragenics Inc | -1.544M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -4.878M |
| Cash from Financing (Quarterly) | 15.60M |
| Free Cash Flow | -92.43M |
| Free Cash Flow Per Share (Quarterly) | -0.4897 |
| Free Cash Flow Yield | -14.32% |